about
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditisHuman herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the diseaseHard surface biocontrol in hospitals using microbial-based cleaning productsImpact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome RemodulationPresence of HHV-6A in Endometrial Epithelial Cells from Women with Primary Unexplained InfertilityDetection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis.Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection.HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis.Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infectionU94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesisIdentification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors.Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.Detection of Chlamydophila pneumoniae and human herpesvirus 8 in primary cutaneous anaplastic large-cell lymphoma: a case report.Activating transcription factor 4 (ATF4) is upregulated by human herpesvirus 8 infection, increases virus replication and promotes proangiogenic properties.Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings.Detection of HHV-6-specific mRNA and antigens in PBMCs of individuals with chromosomally integrated HHV-6 (ciHHV-6).Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication.Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection.HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines.High prevalence of specific KIR types in patients with HHV-8 positive cutaneous vascular lesions: a possible predisposing factor?Acute human herpesvirus-6A infection of human mesothelial cells modulates HLA molecules.Panbacterial real-time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™.High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus.Molecular interactions between porcine and human gammaherpesviruses: implications for xenografts?Role of protein kinase C in the phosphatidylserine-induced inhibition of DNA synthesis in blood mononuclear cells.Detection of human herpesvirus 8 sequences in cutaneous cherry angiomas.Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection.Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells.Human herpesvirus 7, Epstein-Barr virus and human cytomegalovirus in periodontal tissues of periodontally diseased and healthy subjects.A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.Detecting recombination in TT virus: a phylogenetic approach.Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.Parotid localized Castleman's disease and HHV-8 infection: a case report.Transient expression of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 enhances HIV-1 replication.Erratum: Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents [Corrigendum]Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention studyEfficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agentsShort Communication: Activating Transcription Factor 4 (ATF4) Promotes HIV Type 1 ActivationPAX2 expression by HHV-8-infected endothelial cells induced a proangiogenic and proinvasive phenotype
P50
Q21131390-970A4617-7E39-41CA-8F56-5E4EE7EC3D9BQ28278472-FE154588-3588-4B13-99F1-8BDC82ADD73BQ28543303-04B5E455-EB8B-40DA-805F-99DDCC2A50DCQ28550229-D720DE4B-BEB5-4BD6-9058-D2EA0927DDDEQ29039421-914A1C40-839E-416F-899D-AD4E54FD7D8FQ34438108-3D100AEC-EE1D-4941-8CA4-8AA2B9BE461EQ34674418-2D86B0F5-FBDA-4506-B5CC-329A12CB6717Q34680510-82B57E41-7C21-4749-8C77-AC460BE57EE1Q37064368-45FF5524-8162-4DEA-88F9-289B1888BC3EQ37453582-5CA64FC1-3293-4CD0-82B2-F7534566135CQ38902001-0733B246-3DE2-40CA-B060-87B964440DCAQ38902805-EAFC8D66-E869-45F4-958F-88A5EED4F21FQ39338446-A8D202D8-1B3D-4A22-9BC2-8C5314D38EF0Q39455107-4C9ECB6F-6ADB-4693-B901-25B0ED16241DQ40147387-AF475FF3-5C96-488E-B6D2-8EABF30FE469Q40182260-B9BCAA60-F43D-4FDD-85C9-AB319773084DQ40337961-A8C9724C-A037-4FC2-81DB-59232F4459FAQ40655838-05741AD0-742F-4CF9-BAD0-49F0096C82B8Q40718464-5D7D60F4-2FEE-4A59-B194-947131B97413Q40722451-B1124E11-5413-4DF3-AE26-1F8A47631B02Q41153901-58375BE3-38F9-467B-A60B-CC117C3D5A48Q42181930-A36EE025-8A2F-4AFC-A8DF-D80C366D0326Q42244344-BA35C4D4-C9CC-451E-8DFF-9C5EC2977473Q43220723-841C1AD1-5C73-4C12-A5AF-7D42790A6C51Q43492567-12D9B441-78ED-4776-8D84-016B2380B3D3Q43607335-E6F0E319-CC3C-48E9-8061-1499BB60E083Q43707263-9541B2EB-61E3-4688-92EA-C13083465624Q44243777-FDE83A33-81E4-411E-BCD9-9445FF5E90E6Q44324779-FB685DA2-38A6-44D1-8BC5-41815BE62171Q45014374-B3250ED0-5C92-43B4-8E0A-6BA9BEFAD414Q45355670-07D96FF5-A0E3-48BF-A20F-7E33231E7C75Q45730337-43179FF7-909A-410A-B1B8-123A4249F78AQ46606593-F9E2FC32-F639-43ED-AE52-1250EF717440Q53461889-D4E773E2-1D68-486B-93D7-6039A9A2A98AQ53858650-3FFAE487-8B43-4970-9ABC-149AD33B7A35Q57071891-6B5775A1-5AEC-4BB5-A843-13194E7A5A43Q58620053-11115E2E-0D7F-4A83-B63B-3C8C635B5AECQ58620055-BF3ABCF4-0053-47FB-81A2-95278B42F8F5Q58620069-AC6BD9CC-36B3-4E3B-AFE6-139D39B5D5EDQ58620070-00C9222C-917B-4BF2-A6ED-A35133681EC5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elisabetta Caselli
@ast
Elisabetta Caselli
@en
Elisabetta Caselli
@es
Elisabetta Caselli
@nl
Elisabetta Caselli
@sl
type
label
Elisabetta Caselli
@ast
Elisabetta Caselli
@en
Elisabetta Caselli
@es
Elisabetta Caselli
@nl
Elisabetta Caselli
@sl
prefLabel
Elisabetta Caselli
@ast
Elisabetta Caselli
@en
Elisabetta Caselli
@es
Elisabetta Caselli
@nl
Elisabetta Caselli
@sl
P1053
H-1513-2012
P106
P1153
7003824713
P21
P31
P3829
P496
0000-0001-6048-9141